Telix Pharmaceuticals Ltd

TLX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0002007191

SEC filings (opens in a new tab)

No open-market purchases or sales by Telix Pharmaceuticals Ltd insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $36.6M in total; no superinvestor holds it.

Other share classesTLPPF

Q2 2026 vs. Q1 2026

How the institutions holding Telix Pharmaceuticals Ltd changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of TLX: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	40	1	62	+23
Shares	2.57M	1.43K	3.18M	+610.1K (+23.8%)
Value	$24.5M	$13.6K	$36.6M	+$12.1M (+49.6%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Telix Pharmaceuticals Ltd at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to TLX in Q2 2026
Institution	Shares	Value	% of portfolio
Marshall Wace, LLP	189,188	$2.18M	0.00%
Hennion & Walsh Asset Management, Inc.	150,138	$1.73M	0.05%
Blair William & Co	122,985	$1.42M	0.00%
Quadrature Capital Ltd	102,425	$1.18M	0.01%
NLB Skladi, upravljanje premozenja, d.o.o.	58,000	$668.7K	0.03%
Capricorn Fund Managers Ltd	36,100	$416.2K	0.03%
GTS Securities LLC	35,537	$409.7K	0.01%
Jane Street Group, LLC	33,389	$385.0K	0.00%
SummitTX Capital, L.P.	31,621	$364.6K	0.01%
HRT Financial LP	25,637	$295.0K	0.00%
HSBC Holdings PLC	16,488	$190.4K	0.00%
Brinker Capital Investments, LLC	15,618	$180.1K	0.00%
Virtu Financial LLC	12,634	$146.0K	0.00%
Natixis	10,999	$126.9K	0.00%
Two Sigma Investments, LP	10,233	$118.0K	0.00%
Clearstead Advisors, LLC	2,112	$24.4K	0.00%
Royal Bank of Canada	1,500	$17.0K	0.00%
Jones Financial Companies LLLP	889	$9.48K	0.00%
GAMMA Investing LLC	278	$3.21K	0.00%
Signaturefd, LLC	148	$1.71K	0.00%
Ameritas Advisory Services, LLC	90	$1.04K	0.00%
Silver Grove Financial Group, Inc.	78	$899	0.00%
Bogart Wealth, LLC	26	$300	0.00%
Caitong International Asset Management Co., Ltd	11	$127	0.00%

Sold out (1)

Institutions that held Telix Pharmaceuticals Ltd at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of TLX in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Schonfeld Strategic Advisors LLC	34,873	$333.7K

Not filed for Q2 2026 yet (1)

Institutions that held Telix Pharmaceuticals Ltd at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TLX in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
CWM, LLC	1,425	$13.6K